Frontiers | Reducing Cardiovascular Risk Factors in Patients with Diabetes Mellitus

Reducing Cardiovascular Risk Factors in Patients with Diabetes Mellitus

4,841
Total downloads
17k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 19 Dec 2023

The global burden of cardiovascular diseases and type 2 diabetes attributable to low physical activity, 1990–2019: an analysis from the global burden of disease study

Junhan Zhang
Zongxiang Yuan
Chuye Mo
Yiwen Kang
Fengyi Wang
Xueqin Wei
Shihui Huang
Fang Qin
Junjun Jiang
1 more
Li Ye

The global burden of cardiovascular diseases and type 2 diabetes attributable to low physical activity, 1990–2019: an analysis from the global burden of disease study

doi 10.3389/fcvm.2023.1247705

2,752 views
2 citations

REVIEW

Published on 26 Sep 2023

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines

Pierre Gourdy
François Schiele
Jean-Michel Halimi
Serge Kownator
Samy Hadjadj
Paul Valensi

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines

doi 10.3389/fcvm.2023.1227769

5,980 views
5 citations

ORIGINAL RESEARCH

Published on 03 Mar 2023

Causal association between sleep traits and the risk of coronary artery disease in patients with diabetes

Mengyun Tian
Hongchuang Ma
Jiaxi Shen
Teng Hu
Hanbin Cui
Ning Huangfu

Causal association between sleep traits and the risk of coronary artery disease in patients with diabetes

doi 10.3389/fcvm.2023.1132281

1,221 views
2 citations

ORIGINAL RESEARCH

Published on 06 Feb 2023

Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats

Takuya Koizumi
Masaya Watanabe
Takashi Yokota
Masumi Tsuda
Haruka Handa
Jiro Koya
Kotaro Nishino
Daishiro Tatsuta
Hiroyuki Natsui
7 more
Toshihisa Anzai

Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats

doi 10.3389/fcvm.2023.1005408

3,247 views
23 citations

ORIGINAL RESEARCH

Published on 09 Jan 2023

Proteome-wide analysis of lysine β-hydroxybutyrylation in the myocardium of diabetic rat model with cardiomyopathy

Weiguang Luo
Mei He
Qizhi Luo
Yi Li

Proteome-wide analysis of lysine β-hydroxybutyrylation in the myocardium of diabetic rat model with cardiomyopathy

doi 10.3389/fcvm.2022.1066822

2,240 views
3 citations

Share on

Frontiers in Cardiovascular Medicine

Frontiers in Cardiovascular Medicine

Cardiovascular Metabolism

Impact

17kTopic views
11kArticle views
4,841Article downloads